 The purpose of this study is to investigate whether the drug BG00012 can improve the symptoms of rheumatoid arthritis RA in patients who are already taking methotrexate for RA, but who still suffer symptoms of RA. The purpose is also to ensure that the combination of methotrexate is safe for patients to take and that any side effects are acceptable to patients with RA. 